Detalles de la búsqueda
1.
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
J Immunol
; 194(8): 3723-34, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25762782
2.
SOM230: a new therapeutic modality for Cushing's disease.
Chimia (Aarau)
; 68(7-8): 483-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25437387
3.
Maintained partial protection against Streptococcus pneumoniae despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine.
Clin Transl Immunology
; 11(1): e1366, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35003749
4.
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration.
Front Immunol
; 13: 814064, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967378
5.
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.
mSphere
; 6(3)2021 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952667
6.
Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
Exp Neurol
; 335: 113488, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991933
7.
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.
Bioorg Med Chem Lett
; 20(12): 3628-31, 2010 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20483608
8.
Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
Transpl Int
; 23(5): 543-52, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20003043
9.
The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae.
Front Immunol
; 11: 611661, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33584691
10.
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation.
J Neuroimmune Pharmacol
; 14(4): 709-719, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31435856
11.
Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Front Immunol
; 10: 2437, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31681317
12.
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.
Front Immunol
; 10: 1340, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31281311
13.
Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot.
Cytometry A
; 73(9): 799-807, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18548611
14.
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Eur J Endocrinol
; 152(4): 645-54, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15817922
15.
SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs.
Endocrinology
; 143(10): 4123-30, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12239124
16.
The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats.
Endocrinology
; 143(8): 2944-52, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12130560
17.
The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion.
J Clin Endocrinol Metab
; 89(6): 3027-32, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15181094
18.
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
J Clin Endocrinol Metab
; 89(4): 1577-85, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15070915
19.
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
J Clin Endocrinol Metab
; 89(2): 638-45, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14764775
20.
A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
J Med Chem
; 46(12): 2334-44, 2003 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12773038